ATPase secretory pathway Ca2+ transporting 1
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La ATP2C1 gene provides instructions for making a protein called hSPCA1. This protein is an adenosine triphosphate (ATP)-powered calcium pump, which uses energy from ATP molecules to pump charged calcium atoms (calcium ions) across cell membranes. Specifically, the hSPCA1 protein transports calcium ions into a cell structure called the Golgi apparatus, where they are stored until needed. The appropriate storage and release of calcium is essential for many cell activities, including cell growth and division (proliferation), cell movement (migration), and attachment of cells to one another (cell adhesion).
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La ATP2C1 gene provides instructions for making a protein called hSPCA1. This protein is an adenosine triphosphate (ATP)-powered calcium pump, which uses energy from ATP molecules to pump charged calcium atoms (calcium ions) across cell membranes. Specifically, the hSPCA1 protein transports calcium ions into a cell structure called the Golgi apparatus, where they are stored until needed. The appropriate storage and release of calcium is essential for many cell activities, including cell growth and division (proliferation), cell movement (migration), and attachment of cells to one another (cell adhesion).
The hSPCA1 protein also transports manganese ions into the Golgi apparatus. Manganese works with a variety of enzymes and is involved in processing newly formed proteins.
The hSPCA1 protein is present in cells throughout the body. It appears to be particularly important for the normal function of cells called keratinocytes, which are found in the outer layer of the skin (the epidermis). In addition to proliferation and adhesion, calcium regulation in these cells appears to play an important role in maintaining the skin's barrier function, helping to keep foreign invaders such as bacteria out of the body.
Conditions referring to this gene or chromosome
Other names
AT2C1_HUMAN
ATP-dependent Ca(2+) pump PMR1
ATP2C1A
ATPase 2C1
ATPase, Ca(2+)-sequestering
ATPase, Ca++ transporting, type 2C, member 1
BCPM
calcium-transporting ATPase type 2C member 1
HHD
hSPCA1
HUSSY-28
KIAA1347
PMR1
secretory pathway Ca2+/Mn2+ ATPase 1
SPCA1
Related patient information and medicines

Patient information leaflet
Puis-je prendre Apixaban et Empagliflozin ensemble ?
It is generally considered safe to take these two medications together. Why this happens Apixaban (a blood thinner) and empagliflozin (a diabetes medication) are processed by different pathways in the body. Apixaban is mainly broken down by specific liver enzymes (CYP3A4) and a transport protein (P-gp), while empagliflozine est transformée through a.

Patient information leaflet
Traitement du diabète de type 2
Gestion diabète de type 2 Keeping your blood sugar (glucose) well controlled is key to reducing your risk of long-term complications such as heart, kidney or eye problems. Regardless of whether you need medication or which medication you are taking, diet an... These actions include: Stimulating insulin secretion dans response à glucose; and.

Patient information leaflet
Puis-je prendre Mirabegron et Rivaroxaban ensemble ?
Taking these two medicines together is generally considered sa... Why this happens Mirabegron Mirabegron for urinary symptoms and rivaroxaban Rivaroxaban tablets are processed by different pathways in the body. Mirabegron is primarily broken down by enzymes called CYP3A4 and CYP2D6, while rivaroxaban is processed by CYP3A4 and a transport protein.

Patient information leaflet
Dépistage du syndrome de Down
See the separate leaflet called syndrome de Down for. What increases your chance of having a baby with Down's syndrome. Anyone can have a baby with Down's syndrome but a woman's chance increases as she becomes older. Large studies have been carried out to look at the chance of Down's syndrome related to a mother's age and have shown that: A.

Patient information leaflet
Puis-je prendre Alogliptine et Apixaban ensemble ?
It is generally considered safe to take these two medications together. Why this happens Alogliptin (a diabetes medication) and apixaban (a blood thinner) are processed by different pathways in the body. Alogliptin is primarily excreted unchanged by the kidneys, while apixaban is processed by specific liver enzymes (CYP3A4) and a transport protein.

Patient information leaflet
Puis-je prendre Allopurinol et Rosuvastatine ensemble ?
However, both drugs can rarely affect the liver or cause muscle-related side effects, so it is important to be aware of any new symptoms. Why this happens Allopurinol (used for gout) and rosuvastatin (a statin for cholesterol) are processed by different pathways in the body. Allopurinol is primarily cleared by the kidneys, while rosuvastatin is.
Lectures complémentaires et références
- ATPase secretory pathway Ca2+ transporting 1; MedlinePlus, National Library of Medicine.
- Behne MJ, Tu CL, Aronchik I, Epstein E, Bench G, Bikle DD, Pozzan T, Mauro TM. Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2+ stores. J Invest Dermatol. 2003 Oct;121(4):688-94. doi: 10.1046/j.1523-1747.2003.12528.x.
- Dobson-Stone C, Fairclough R, Dunne E, Brown J, Dissanayake M, Munro CS, Strachan T, Burge S, Sudbrak R, Monaco AP, Hovnanian A. Hailey-Hailey disease: molecular and clinical characterization of novel mutations in the ATP2C1 gene. J Invest Dermatol. 2002 Feb;118(2):338-43. doi: 10.1046/j.0022-202x.2001.01675.x.
- Hu Z, Bonifas JM, Beech J, Bench G, Shigihara T, Ogawa H, Ikeda S, Mauro T, Epstein EH Jr. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet. 2000 Jan;24(1):61-5. doi: 10.1038/71701.
- Missiaen L, Dode L, Vanoevelen J, Raeymaekers L, Wuytack F. Calcium in the Golgi apparatus. Cell Calcium. 2007 May;41(5):405-16. doi: 10.1016/j.ceca.2006.11.001. Epub 2006 Nov 30.
- Missiaen L, Raeymaekers L, Dode L, Vanoevelen J, Van Baelen K, Parys JB, Callewaert G, De Smedt H, Segaert S, Wuytack F. SPCA1 pumps and Hailey-Hailey disease. Biochem Biophys Res Commun. 2004 Oct 1;322(4):1204-13. doi: 10.1016/j.bbrc.2004.07.128.
- Sudbrak R, Brown J, Dobson-Stone C, Carter S, Ramser J, White J, Healy E, Dissanayake M, Larregue M, Perrussel M, Lehrach H, Munro CS, Strachan T, Burge S, Hovnanian A, Monaco AP. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet. 2000 Apr 12;9(7):1131-40. doi: 10.1093/hmg/9.7.1131.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

